Search
BioXcel Therapeutics Inc
BTAIAdd to Watchlist
0.075USD
+0.008+11.94%
Close 09-04 16:00（ET）
2.32MMarket Cap
LossP/E TTM
BioXcel Therapeutics Inc (BTAI) Stock Price Target & Forecast
Analyst Rating
Based on 5 analysts giving stock ratings to BioXcel Therapeutics Inc in the past month.
--
0 Strong Buy
4 Buy
0 Hold
1 Sell
0 Strong Sell
Target Price
1.000USD+1253.18%
BTAI Analyst Recommendation Trends
In the current month, BTAI has received 4 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. BTAI average Analyst price target in the last month is 1.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
5
5
5
5
5
5
5
5
BTAI Analyst Rating for Peer Comparison
Updated: Sep 20, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
Biogen Inc
BIIB
7
17
12
1
0
37
Amgen Inc
AMGN
4
12
18
2
1
37
Eli Lilly and Co
LLY
10
17
6
1
0
34
AbbVie Inc
ABBV
8
19
6
0
0
33
Merck & Co Inc
MRK
8
14
10
0
0
32
Pfizer Inc
PFE
5
6
19
1
1
32
Gilead Sciences Inc
GILD
7
18
6
0
0
31
Vertex Pharmaceuticals Inc
VRTX
9
16
5
0
1
31
Alnylam Pharmaceuticals Inc
ALNY
5
18
7
0
0
30
Regeneron Pharmaceuticals Inc
REGN
6
14
10
0
0
30
Financial Forecasting
Based on analysts' estimates, BTAI EPS is projected to reach -1.010 in FY2026Q3, following reported EPS of -0.486 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.75
-0.82
-0.51
-1.01
-0.72
Actual
-0.57
-0.54
-0.49
--
--
Surprise
+23.47%
+34.63%
+5.41%
--
--
FAQs
What is BioXcel Therapeutics Inc's expected revenue for the next quarter?
BioXcel Therapeutics Inc's expected revenue is 190.00K.
What is BioXcel Therapeutics Inc's price target?
Analysts forecast that BioXcel Therapeutics Inc's price target is USD 12.00, with the highest forecast at USD 38.00 and the lowest forecast at USD 1.00.
How have BioXcel Therapeutics IncBTAI's recent earnings per share performed?
The market expectation was USD -0.49, while BioXcel Therapeutics IncBTAI's earnings per share (EPS) for the previous quarter was USD -0.54. EPS for the next quarter is expected at USD -1.01.